TickerFacts.

Dare Bioscience, Inc. (DARE): Cost of Revenue

Annual figures by period end, from SEC filings.

$295.8K
Year ended 2025-12-31
$858.0K
Trailing 12 months to 2026-06-30
2024-12-31: $02025-12-31: $295.8K$295.8K
2024-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$295.8Kn/a2026-03-26, From 2025-01-01
2024-12-31$0n/a2026-03-26, From 2024-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Dare Bioscience, Inc. (DARE)2025-12-31$295.8Kn/a
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$781.7K+103.2%
Bespoke Extracts, Inc. (BSPK)2024-12-31$664.5K+50.2%
China SXT Pharmaceuticals, Inc. (SXTC)2026-03-31$889.4K-35.2%
Longeveron Inc. (LGVN)2025-12-31$396.0K-22.0%
IGC Pharma, Inc. (IGC)2025-03-31$652.0K+6.5%
Onconetix, Inc. (ONCO)2025-12-31$182.5K-87.6%
Hyperion Defi, Inc. (HYPD)2025-12-31$303.3K-92.3%
Cannapharmarx, Inc. (CPMD)2025-12-31$3.45M-8.2%

Compare DARE, SXTP, BSPK, SXTC side by side · Screen every company in Pharmaceutical Preparations ↗